The influence of hemodialysis membrane permeability on serum paraoxonase-1 activity and oxidative status parameters

Artificial Organs

Volumn 35, Issue 10, 2011, Pages 923-929

  Horoz, Mehmet ^a   Kiykim, Ahmet A ^a   Cimen, Burak ^a   Erdem, Abdullah ^b  

^a MERSIN UNIVERSITY   (Turkey)

^b MERSIN STATE HOSPITAL   (Turkey)

Author keywords

Hemodialysis; Membrane permeability; Oxidative stress; Paraoxonase 1

Indexed keywords

BLOOD; HEMODIALYZERS; MEMBRANES; OXIDATIVE STRESS; PATIENT TREATMENT;

ARYLESTERASE; ENZYMES ACTIVITY; HAEMODIALYSIS; HAEMODIALYSIS MEMBRANES; HEMODIALYSIS PATIENT; HIGH FLUX; LOW FLUX; MEMBRANE PERMEABILITY; PARAOXONASE 1; STRESS PARAMETER;

DIALYSIS;

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN; TRIACYLGLYCEROL; UREA;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS MEMBRANE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MALE; MEMBRANE PERMEABILITY; OUTCOME ASSESSMENT; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

TOSCANA VIRUS;

EID: 80053646095     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2010.01197.x     Document Type: Article

References (30)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112-9.
2. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003;18:1272-80.
3. Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST. The paraoxonase gene family and atherosclerosis. Free Radic Biol Med 2005;38:153-63.
4. Dirican M, Akça R, Sarandol E, Dilek K. Serum paraoxonase activity in uremic predialysis and haemodialysis patients. J Nephrol 2004;17:813-8.
5. Küchle C, Fricke H, Held E, Schiffl H. High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis. Am J Nephrol 1996;16:484-8.
6. Chauveau P, Nguyen H, Combe C, etal. Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis 2005;45:565-71.
7. Götz AK, Böger CA, Popal M, Banas B, Krämer BK. Effect of membrane flux and dialyzer biocompatibility on survival in end-stage diabetic nephropathy. Nephron Clin Pract 2008;109:c154-60.
8. Yokoyama H, Kawaguchi T, Wada T, etal. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in Japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study. Nephron Clin Pract 2008;109:c100-8.
9. Krane V, Krieter DH, Olschewski M, etal. Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis. Am J Kidney Dis 2007;49:267-75.
10. Cheung AK, Levin NW, Greene T, etal. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003;14:3251-63.
11. Macías Núñez JF, Ghais Z, Bustamante J, Lopez-Novoa JM. Evaluation of oxidant-antioxidant balance in patients on maintenance haemodialysis: a comparative study of dialyzers membranes. Nephron Clin Pract 2009;114:c67-73.
12. Chu PL, Chiu YL, Lin JW, Chen SI, Wu KD. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance. Blood Purif 2008;26:213-20.
13. Kerr PG, Sutherland WH, de Jong S, Vaithalingham I, Williams SM, Walker RJ. The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial. Am J Kidney Dis 2007;49:533-9.
14. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-11.
15. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112-9.
16. Harma M, Harma M, Kocyigit A, Erel O. Increased DNA damage in patients with complete hydatidiform mole. Mutat Res 2005;583:49-54.
17. Miyata T, Sugiyama S, Saito A, Kurokawa K. Reactive carbonyl compounds related uremic toxicity ("carbonyl stress"). Kidney Int 2001;78 (Suppl.): S25-31.
18. Handelman GJ, Walter MF, Adhikarla R, etal. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int 2001;59:1960-6.
19. Oberg BP, McMenamin E, Lucas FL, etal. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004;65:1009-16.
20. Descamps-Latscha B, Goldfarb B, Nguyen AT, etal. Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study. Nephron 1991;59:279-85.
21. Miyata T, Wada Y, Cai Z, etal. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997;51:1170-81.
22. Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004;24:469-673.
23. Paragh G, Seres I, Balogh Z, etal. The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia. Nephron 1998;80:166-70.
24. Juretic D, Tadijanovic M, Rekic B, Simeon-Rudolf V, Reiner E, Baricic M. Serum paraoxonase activities in hemodialyzed uremic patients: cohort study. Croat Med J 2001;42:146-50.
25. Aviram M, Rosenblat M, Billecke S, etal. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radical Biol Med 1999;26:892-904.
26. Gugliucci A, Mehlhaff K, Kinugasa E, etal. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance. Clin Chim Acta 2007;377:213-20.
27. Ward RA, Ouseph R, McLeish KR. Effects of high-flux hemodialysis on oxidant stress. Kidney Int 2003;63:353-9.
28. Wayner DD, Burton GW, Ingold KU, Barclay LR, Locke SJ. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim Biophys Acta 1987;924:408-19.
29. Harma M, Harma M, Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 2003;133:563-6.
30. Bolukbas C, Bolukbas FF, Horoz M, Aslan M, Celik H, Erel O. Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis 2005;5:95.